Inactive Instrument

Highlights Intermolecular Inc

Equities

US45882D1090

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Intermolecular, Inc. Announces the Relocation of the Silicon Valley Innovation Hub from Menlo Park to San Jose Facilities	21-03-04	CI
Intermolecular, Inc. Announces Breakthrough Four-Element ALD Chalcogenide-based OTS for 3D Memory Arrays	20-06-16	CI
MERCK Kommanditgesellschaft auf Aktien (DB:MRK) completed the acquisition of Intermolecular, Inc..	19-09-19	CI
Intermolecular, Inc.'s Equity Buyback announced on November 6, 2018, has expired.	19-09-19	CI
Intermolecular, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-08	CI
Intermolecular, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-14	CI
MERCK Kommanditgesellschaft auf Aktien (DB:MRK) signed a definitive agreement to acquire Intermolecular, Inc. for $61.9 million.	19-05-05	CI
Tranche Update on Intermolecular, Inc.'s Equity Buyback Plan announced on November 6, 2018.	19-03-08	CI
Intermolecular, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2018; Provides Earnings Guidance for the First Quarter of 2019	19-02-12	CI
Intermolecular, Inc. announces an Equity Buyback for $10 million worth of its shares.	18-11-06	CI
Intermolecular, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2018; Provides Earnings Guidance for the Quarter Ending December 31, 2018	18-11-06	CI
Intermolecular, Inc. authorizes a Buyback Plan.	18-11-01	CI
Intermolecular, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2018; Provides Earnings Guidance for the Third Quarter of 2018; Provides Earnings Guidance for the Full Years 2018 and 2019	18-08-06	CI
Intermolecular Defines ALD Process for Efficient Composition Tuning of 3D Crosspoint NVM Selectors	18-07-10	CI
Intermolecular, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2018; Provides Earnings Guidance for the Second Quarter Ending June 30, 2018	18-05-08	CI
Intermolecular Seeks Acquisitions	18-03-02	CI
Intermolecular, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2017; Provides Earnings Guidance for the First Quarter of 2018	18-02-13	CI
Intermolecular and SITRI Form Strategic Alliance to Accelerate Materials Innovation	17-11-20	CI
Intermolecular, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2017; Provides Earnings Guidance for the Fourth Quarter Ending December 31, 2017	17-11-02	CI
Intermolecular, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2017; Provides Earnings Guidance for the Second Half of 2017	17-08-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Intermolecular Inc

Equities

US45882D1090

Highlights

Filters